Springbok Analytics, a Charlottesville, VA-based company providing technology that transforms static 2D imagery into precise 3D muscle assessments, raised $3M in Seed funding.
The round was led by Transition Equity Partners, with participation from the NHL’s Chicago Blackhawks, the FSHD Global Research Foundation, and follow-on investments from Titletown Tech, CAV Angels and early angel investors.
The company intends to use the funds to expand operations and its business reach.
Led by CEO Scott Magargee, Springbok provides technology that transforms standard, 2D magnetic resonance image (MRI) data into personalized 3D muscle visualizations for athletic, performance and health applications. A Springbok scan takes less than 15 minutes and unlocks a new way to view and quantify muscle volume, asymmetries, and atrophy, as well as soft tissue injuries and scar tissue.
This funding announcement follows Springbok’s recent selection into the NBA’s Launchpad program, the league’s initiative to source, evaluate and pilot emerging technologies that advance the league’s priorities, which include improving soft tissue injury prevention and recovery efforts.
The company is also supporting the important research and care for a range of musculoskeletal and neuromuscular conditions, including facioscapulohumeral muscular dystrophy (FSHD).
FinSMEs
25/04/2023